Find clinical trials for Triple Negative Breast Cancer in Baltimore, MD
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Baltimore, MD, USA:
doxorubicin (PLD, Doxil) are safe and effective at controlling the cancer in patients with metastatic triple negative breast...
Phase 1
Baltimore, Maryland, United States and 5 other locations
This randomized phase II trial studies how well carboplatin with or without atezolizumab works in treating patients with stage IV triple negative...
Phase 2
Baltimore, Maryland, United States and 5 other locations
of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...
Phase 1, Phase 2
Columbia, Maryland, United States and 46 other locations
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...
Phase 3
Washington, District of Columbia, United States and 70 other locations
in patients with unresectable, locally advanced or metastatic triple-negative breast cancer (TNBC) who received a...
Phase 2
Fairfax, Virginia, United States and 21 other locations
This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...
Phase 2
Washington, District of Columbia, United States and 12 other locations
This pilot study will provide preliminary data regarding the role of PIS in predicting the benefit of immune checkpoint inhibition with or without ch...
Phase 2
Washington, District of Columbia, United States and 3 other locations
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...
Phase 1, Phase 2
Baltimore, Maryland, United States and 49 other locations
selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...
Phase 2
Baltimore, Maryland, United States and 23 other locations
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Baltimore, Maryland, United States and 216 other locations
Clinical trials
Research sites
Resources
Legal